Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Published online Sep 20, 2026. doi: 10.5662/wjm.116058
Table 5 Cognitive outcomes by anesthetic agent
| Ref. | Cognitive assessment tool | Propofol | Etomidate | Ketamine | P value |
| Zhong et al[14], 2016 | MMSE, TMT-A, TMT-B | - | - | Dose-dependent improvement | < 0.05 |
| Bernardoff et al[15], 2026 | MoCA, RBANS | Moderate impairment | Mild impairment | - | < 0.05 |
| Krystal et al[16], 2003 | MMSE, orientation | - | - | Less impairment | < 0.01 |
| Kavakbasi et al[24], 2023 | MMSE, clock drawing | Moderate impairment | Mild impairment | - | < 0.05 |
| Yang et al[8], 2025 | MoCA, RBANS | Variable | - | - | NS |
| Guha et al[19], 2022 | MMSE | Moderate impairment | - | Mild impairment | < 0.05 |
- Citation: Tilokani H, Jawed I, Shehzadi A, Ali A, Khan A, Qadir U, Bin Gulzar AH, Zahid R, Khan S, Mal M, Zakeri MA, Aslam H, Siddique MU. Impact of different anesthetic agents (propofol, etomidate, ketamine) on seizure duration and cognitive recovery in electroconvulsive therapy. World J Methodol 2026; 16(3): 116058
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/116058.htm
- DOI: https://dx.doi.org/10.5662/wjm.116058